Close Menu

NEW YORK (GenomeWeb) – Roche said today that its diagnostics revenues grew 5 percent year over year for the first quarter of 2018, driven by growth across the entire Dx division.

For the three months ended March 31, the Swiss pharmaceutical and diagnostics company reported overall revenues of CHF 13.58 billion ($13.85 billion), up 5 percent from CHF 12.94 billion in Q1 2017.

In diagnostics, Roche reported revenues of CHF 2.91 billion, up from CHF 2.77 billion in 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.